GLP-1 Agonist for Alcohol Use Disorder
November 16, 2024
A new study suggests that glucagon-like peptide-1 receptor (GLP-1) ...
Read More
Smoking Cessation as a Priority for Psychiatrists
September 2, 2024
Smoking rates remain disproportionately high among individuals with...
Read More
Combination OUD Treatment Safe During Pregnancy
August 26, 2024
A recent study explored the comparative safety of prenatal exposure...
Read More
Interactions of CBD and THC with CYP450 Enzymes
May 30, 2024
A recent systematic review evaluated the effect of CBD and THC on t...
Read More
NEI Podcast: Episode 224 - Is Cannabidiol Useful for the Treatment of Opioid Use Disorder?
May 8, 2024
What are the hypothesized neurobiological mechanisms that support t...
Read More
Cyproheptadine-Prazosin Combination for AUD
April 24, 2024
A recent double-blind, parallel group, placebo-controlled Phase 2 c...
Read More
FDA Approves First Test to Help Identify Risk of Opioid Use Disorder
December 23, 2023
The U.S. Food and Drug Administration approved the first genetic te...
Read More
Risk of Progression From Mild or Moderate to Severe Alcohol Use Disorder
October 19, 2023
Predicting the development of severe alcohol use disorder is diffic...
Read More
Substance-Induced Psychosis Tied to Schizophrenia Risk
October 17, 2023
individuals without a history of psychosis were assessed for the li...
Read More
AAFP Updates Alcohol Use Practice Manual
October 8, 2023
The AAFP has recently published an updated practice manual on addre...
Read More
Genetic Link Between Eating Disorders and Alcohol Use
October 2, 2023
Previous research has shown a connection between eating disorders a...
Read More
Integrating Opioid Use Disorder Treatment Into Primary Care Settings
September 7, 2023
Opioid use disorder (OUD) is undertreated even though there are eff...
Read More